Hazelden Betty Ford Foundation
-
Services:
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Hepatitis education, counseling, or support
- Group counseling
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Outpatient day treatment or partial hospitalization
- Residential/24-hour residential
- Short-term residential
- Residential detoxification
- Outpatient
- Social skills development
- Case management service
- Early intervention for HIV
- Mental health services
- Suicide prevention services
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- State department of health
- The Joint Commission
- Brief intervention
- Relapse prevention
- Trauma-related counseling
- Cognitive behavioral therapy
- Contingency management/motivational incentives
- 12-step facilitation
- Motivational interviewing
- Substance use disorder counseling
- No formal relationship with prescribing entity
- Sign language services for the deaf and hard of hearing
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Prescribes naltrexone
- Buprenorphine maintenance
- Lofexidine or Clonidine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Prescribes buprenorphine
- Private non-profit organization
- Outcome follow-up after discharge
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Vaping not permitted
- Male
- Female
- Alcohol Detoxification
- Cocaine Detoxification
- Benzodiazepines Detoxification
- Opioids detoxification
- Medication routinely used during detoxification
- Methamphetamines detoxification
- Adults
- Young Adults
- Drug or alcohol urine screening
- HIV testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- STD testing
- Testing for Hepatitis B (HBV)
- TB screening
- Smoking permitted in designated area
- Clients who have experienced trauma
- Adult women
- Clients with co-occurring mental and substance use disorders
- Clients with co-occurring pain and substance use disorders
- Adult men
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Disulfiram
- Buprenorphine without naloxone
- Medication for mental disorders
- Naltrexone (oral)
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Acamprosate (Campral®)
- Nicotine replacement
- Naltrexone (extended-release, injectable)
- Clonidine
- Buprenorphine (extended-release, injectable)
- Private health insurance
- SAMHSA funding/block grants
- Federal military insurance (e.g., TRICARE)
- Cash or self-payment
- Housing services
- Recovery coach
- Self-help groups
- Mentoring/peer support
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Screening for mental disorders
- Complete medical history/physical exam
- Outreach to persons in the community
- Screening for tobacco use
- Screening for substance use
Education and Counseling Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Ancillary Services
Type of Alcohol Use Disorder Treatment
License/Certification/Accreditation
Treatment Approaches
External Source of Medications Used for Alcohol Use Disorder Treatment
Language Services
Opioid Medications used in Treatment
Type of Opioid Treatment
Facility Operation (e.g., Private, Public)
Transitional Services
Facility Vaping Policy
Gender Accepted
Detoxification (medical withdrawal) Services
Age Groups Accepted
Testing
Facility Smoking Policy
Special Programs/Groups Offered
Pharmacotherapies
Payment/Insurance/Funding Accepted
Recovery Support Services
Type of Care
Assessment/Pre-treatment